Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Study of the effect of marketed Chinese patent medicine on inhibiting collagen deposition in fibroblasts models
Hits 1610  Download times 937  Received:March 06, 2020  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2020.06.06
Key Words   Chinese patent medicine;fibroblasts;collagen deposition;COVID-19
Author NameAffiliationE-mail
YANG Jian Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
HAN Lifeng Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
SHAO Rui Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
ZHANG Peng Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
HAO Jia Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
CHANG Yanxu Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
GAO Xiumei Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
WANG Tao Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China wangtao@tjutcm.edu.cn 
Abstract
    [Objective] The respiratory system infected by virus normally causes lung injury,subsequently followed by pulmonary fibrosis. This process is related to several pathological processes,such as recruitment of lung fibroblasts,collagen deposition and extracellular matrix remodeling. Currently,there is no effective therapeutic drugs in the clinic. This experiment was aim to get the marketed Chinese patent medicine with the effect of collagen deposition inhibiting.[Methods] In this paper,we screened marketed Chinese patent medicines by Sirius Red staining method using collagen deposition models of human-derived lung fibroblasts and murine-derived fibroblasts.[Results] A few marketed medicines with significant inhibition in collagen deposition both in embryonic fibroblast of mice and human fibroblasts models were screened out.[Conclusion] The results suggest that these marketed Chinese patent medicines are expected to have more promising clinical applications,and provide the basis for drug selection for the later COVID-19 rehabilitation treatment.

You are the 2318301 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.